Lapatinib in Combination With Vinorelbine

Update Il y a 5 ans
Reference: NCT01013740

Woman Man

Extract

This is a randomized, parallel-arm, open-label, multi-centre, Phase II study to determine the efficacy and safety of lapatinib in combination with vinorelbine or capecitabine in women with ErbB2 overexpressing metastatic breast cancer (MBC) who have received no more than one chemotherapeutic regimen in the metastatic setting.


Inclusion criteria

  • Cancer


Links